Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [911]
News [3678]
Articles [22]
Editorials [1]
Conferences [135]
elearning [0]
Targets for therapy in ETP-ALL
Prof Jan Cools - University of Leuven, Belgium
Targets for therapy in ETP-ALL ( Prof Jan Cools - University of Leuven, Belgium )
27 Jan 2017
The role of autologous transplant in ALL
Prof Sebastian Giebel - Silesian Medical University, Katowice, Poland
The role of autologous transplant in ALL ( Prof Sebastian Giebel - Silesian Medical University, Katowice, Poland )
27 Jan 2017
Next steps for treating breast cancer
Dr Michel Velez - Memorial Healthcare System, Hollywood, FL, USA
Next steps for treating breast cancer ( Dr Michel Velez - Memorial Healthcare System, Hollywood, FL, USA )
6 Jan 2017
Epirubicin and cyclophosphamide before docetaxel in early breast cancer
Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark
Epirubicin and cyclophosphamide before docetaxel in early breast cancer ( Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark )
14 Dec 2016
neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer
Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA
neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer ( Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA )
13 Dec 2016
PARP inhibitory velaparib trialled in BRCA1/2 breast cancer
Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA
PARP inhibitory velaparib trialled in BRCA1/2 breast cancer ( Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA )
13 Dec 2016
PD-1 therapy with eribulin for triple negative MBC
Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA
PD-1 therapy with eribulin for triple negative MBC ( Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA )
9 Dec 2016
Neoadjuvant abemaciclib for HR positive, HER negative breast cancer
Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA
Neoadjuvant abemaciclib for HR positive, HER negative breast cancer ( Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA )
8 Dec 2016
Extended adjuvant endrocine therapy with letrozole after aromatase inhibition
Dr Terry Mamounas - UF Health Center, Orlando, USA
Extended adjuvant endrocine therapy with letrozole after aromatase inhibition ( Dr Terry Mamounas - UF Health Center, Orlando, USA )
7 Dec 2016
Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin...
Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA
Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin lymphoma ( Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA )
6 Dec 2016
ASH 2016 highlights: breaking new ground in haematology
Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy
ASH 2016 highlights: breaking new ground in haematology ( Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy )
6 Dec 2016
ALL: Combining paediatric-type therapy with minimal residual disease
Dr Alessandro Rambaldi - Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
ALL: Combining paediatric-type therapy with minimal residual disease ( Dr Alessandro Rambaldi - Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy )
5 Dec 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation